GOLDMAN SACHS GROUP INC - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 93 filers reported holding ARATANA THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$4,241,000
+1958.7%
821,902
+1337.6%
0.00%
Q1 2019$206,000
-90.5%
57,172
-83.8%
0.00%
-100.0%
Q4 2018$2,170,000
-39.0%
353,961
-41.9%
0.00%0.0%
Q3 2018$3,555,000
+612.4%
608,792
+418.4%
0.00%
Q2 2018$499,000
-79.5%
117,441
-78.8%
0.00%
-100.0%
Q1 2018$2,438,000
+581.0%
552,783
+712.5%
0.00%
Q4 2017$358,000
+15.9%
68,039
+35.1%
0.00%
Q3 2017$309,000
+22.6%
50,362
+44.6%
0.00%
Q2 2017$252,000
-27.4%
34,834
-46.7%
0.00%
Q1 2017$347,000
-19.9%
65,415
+8.6%
0.00%
Q4 2016$433,000
-43.0%
60,250
-25.7%
0.00%
Q3 2016$759,000
+377.4%
81,057
+221.3%
0.00%
Q2 2016$159,000
+98.8%
25,227
+73.8%
0.00%
Q1 2016$80,000
-73.2%
14,514
-72.8%
0.00%
Q4 2015$298,000
+242.5%
53,345
+420.2%
0.00%
Q3 2015$87,000
-98.3%
10,254
-96.5%
0.00%
-100.0%
Q4 2014$5,234,000
+63.9%
293,709
-7.7%
0.00%
+100.0%
Q3 2014$3,194,000
-32.3%
318,072
+5.3%
0.00%0.0%
Q2 2014$4,716,000
-20.2%
302,107
-5.1%
0.00%
-50.0%
Q1 2014$5,909,000
+775.4%
318,392
+800.9%
0.00%
Q4 2013$675,000
-39.1%
35,343
-47.9%
0.00%
Q3 2013$1,109,00067,8900.00%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,093,845$32,685,00011.00%
Broadfin Capital, LLC 1,634,870$25,520,0001.26%
MARXE AUSTIN W & GREENHOUSE DAVID M 600,000$9,366,0001.19%
Grandeur Peak Global Advisors, LLC 179,900$2,808,0000.60%
First Light Asset Management, LLC 52,234$815,0000.55%
Granite Point Capital Management, L.P. 50,000$781,0000.54%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 788,904$12,315,0000.50%
ALYDAR PARTNERS LLC 180,000$2,810,0000.24%
CHARTWELL INVESTMENT PARTNERS, LLC 431,444$6,735,0000.14%
Nicholas Investment Partners, LP 141,127$2,203,0000.13%
View complete list of ARATANA THERAPEUTICS INC shareholders